Key facts
- This page summarizes Jonathan C. Javitt's Form 4 filing for NRX Pharmaceuticals, Inc. (NRXP).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 18 Dec 2024, 08:27.
Jonathan C. Javitt - 17 Dec 2024 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)
- Reporting relationship
- Chairman and Chief Scientist, Director, 10%+ Owner
- Issuer ticker
- NRXP
- Reported as of
- 17 Dec 2024
- Net transaction value
- +$46,800
- SEC form
- 4
- Accepted by SEC
- 18 Dec 2024, 08:27:36 UTC
- Prior SEC filing
- 24 Aug 2023
- Next SEC filing
- 10 Sep 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jonathan C. Javitt
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jonathan C. Javitt filed Form 4 for NRX Pharmaceuticals, Inc. (NRXP) on 18 Dec 2024.
Change
- Previous filing in this sequence was filed on 24 Aug 2023.
- Current net transaction value: +$46,800.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NRXP
transaction
Common Stock
Purchase
- Transaction value
- $46,800
- Shares
- +40,000
- Change %
- +90%
- Price
- $1.17
- Shares after
- 84,634
- Date
- 17 Dec 2024
- Ownership
- Direct
NRXP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,260,000
- Date
- 17 Dec 2024
- Ownership
- By the Jonathan Javitt Living Trust
- Footnotes
- F1
NRXP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 142,200
- Date
- 17 Dec 2024
- Ownership
- By the Javitt 2012 Irrevocable Dynasty Trust
- Footnotes
- F2
NRXP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 30,000
- Date
- 17 Dec 2024
- Ownership
- By the Jonathan Javitt Donor Advised Fund
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Held by the Jonathan Javitt Living Trust of which the reporting person is the trustee.
Footnote F2
Held by the Javitt 2012 Irrevocable Dynasty Trust of which the reporting person is the grantor of such trust. The reporting person is not a trustee or beneficiary of the Trust, and no beneficiary of the Trust resides in the reporting person's household. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Footnote F3
Held by the Jonathan Javitt Donor Advised Fund of which the reporting person is the primary advisor of such fund.